Sector consensus Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 06:56:23 2026-07-08 am EDT			5-day change	1st Jan Change
198.68 ^EUR	-1.30%		+0.86%	+16.06%

Jul. 07	Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
Jul. 01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
LONZA GROUP AG	669.22	+16.51%	23
REVOLUTION MEDICINES, INC.	198.91	+4.43%	22
BEONE MEDICINES AG	413.05	+33.69%	27
IQVIA HOLDINGS INC.	229.63	+10.28%	19
CELLTRION, INC.	256,128.97	+43.73%	24
ASCENDIS PHARMA A/S	257.16	+10.07%	18
MEDPACE HOLDINGS, INC.	445.58	-18.43%	12
IONIS PHARMACEUTICALS, INC.	104.86	+21.47%	22
EUROFINS SCIENTIFIC SE	71.03	+3.06%	14
ICON PUBLIC LIMITED COMPANY	180.81	+7.17%	16
ABIVAX	138.56	+9.28%	6
BIO-TECHNE CORPORATION	69.08	-2.16%	12
TEMPUS AI, INC.	66.06	+9.94%	16
APOGEE THERAPEUTICS, INC.	130.53	-2.26%	12
KYMERA THERAPEUTICS, INC.	123.76	+3.79%	21
ALKERMES PLC	50.19	-9.11%	16
PRAXIS PRECISION MEDICINES, INC.	619.11	+91.11%	18
PROTAGONIST THERAPEUTICS, INC.	120.54	-14.42%	13
QIAGEN N.V.	44.46	+14.83%	14
Average	13,687.45	+12.26%	17
Weighted average by Cap.	20,073.56	+14.21%	19